In-depth mechanistic understanding of novel macrophage-modulating anticancer compounds using state-of-the-art model systems.

• Unité de recherche: INNOSUISSE
• Numéro de projet: 128.411 INNO-LS
• Titre du projet anglais: In-depth mechanistic understanding of novel macrophage-modulating anticancer compounds using state-of-the-art model systems.

Mots-clé (Anglais)

Life sciences, Biotechnology and processing

Résumé des résultats (Abstract) (Anglais)

Abbmira and ZHAW are collaborating to advance Compound42, a drug designed to support the native immune system?s fight against cancer. ZHAW?s experiments using state-of-the art in vitro laboratory-models will generate critical data for guiding further drug-development and future clinical trials.